Interestingly, the activation of the chaperone machinery prevented the formation of p53 nuclear inclusion bodies, for which we have previously shown that they are linked to a worse clinical outcome in colon cancer and glioblastoma [9]. This evidence concerns the gene TP53 and glioblastoma.